Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MKFG
2576
DELISTED
Markforged Holding Corporation
MKFG
| $836K | ﹤0.01% |
69,091
+34,900
| +102% | +$329K |
|
2577
Edgewise Therapeutics
EWTX
$4.13B
| $833K | ﹤0.01% |
107,500
+10,700
| +11% | +$90.2K |
|
2578
JPMorgan US Quality Factor ETF
JQUA
$8.21B
| $832K | ﹤0.01% |
+18,800
| New | +$791K |
|
|
QIPT
2579
DELISTED
Quipt Home Medical
QIPT
| $830K | ﹤0.01% |
155,500
+140,300
| +923% | +$828K |
|
2580
iShares Russell 1000 ETF
IWB
$48.2B
| $829K | ﹤0.01% |
+3,400
| New | +$783K |
|
|
DOG
2581
ProShares Short Dow30
DOG
$100M
| $828K | ﹤0.01% |
+25,600
| New | +$848K |
|
2582
VirTra
VTSI
$34.9M
| $826K | ﹤0.01% |
108,500
+60,900
| +128% | +$406K |
|
2583
Prelude Therapeutics
PRLD
$366M
| $825K | ﹤0.01% |
183,300
+44,800
| +32% | +$268K |
|
2584
Cumberland Pharmaceuticals
CPIX
$100M
| $824K | ﹤0.01% |
560,743
-10,920
| -2% | -$18.8K |
|
2585
California Water Service
CWT
$3.1B
| $822K | ﹤0.01% |
15,914
-61,386
| -79% | -$3.45M |
|
2586
iShares Core Conservative Allocation ETF
AOK
$788M
| $821K | ﹤0.01% |
23,300
-10,400
| -31% | -$364K |
|
|
SRTA
2587
Strata Critical Medical Inc
SRTA
$434M
| $818K | ﹤0.01% |
207,500
+61,400
| +42% | +$195K |
|
|
NSTG
2588
DELISTED
NanoString Technologies, Inc.
NSTG
| $813K | ﹤0.01% |
200,861
-41,039
| -17% | -$303K |
|
2589
ARK Autonomous Technology & Robotics ETF
ARKQ
$1.89B
| $812K | ﹤0.01% |
14,400
+3,200
| +29% | +$159K |
|
|
XRN
2590
Chiron Real Estate Inc
XRN
$514M
| $812K | ﹤0.01% |
17,780
-35,780
| -67% | -$1.62M |
|
2591
Invesco
IVZ
$13.1B
| $809K | ﹤0.01% |
48,100
-1,166,700
| -96% | -$18.8M |
|
2592
National Bankshares
NKSH
$259M
| $808K | ﹤0.01% |
27,670
-1,300
| -4% | -$38.7K |
|
2593
PC Connection
CNXN
$2.11B
| $807K | ﹤0.01% |
17,900
-20,700
| -54% | -$903K |
|
2594
Helios Technologies
HLIO
$2.57B
| $805K | ﹤0.01% |
12,175
-20,200
| -62% | -$1.2M |
|
2595
Assembly Biosciences
ASMB
$498M
| $803K | ﹤0.01% |
58,167
-5,650
| -9% | -$69.4K |
|
|
NOAH
2596
Noah Holdings
NOAH
$580M
| $803K | ﹤0.01% |
57,000
+200
| +0.4% | +$3.13K |
|
2597
Neuronetics
STIM
$138M
| $803K | ﹤0.01% |
373,300
+75,900
| +26% | +$184K |
|
2598
Sportradar
SRAD
$4.3B
| $802K | ﹤0.01% |
62,166
+30,666
| +97% | +$370K |
|
|
HOOK
2599
DELISTED
HOOKIPA Pharma
HOOK
| $801K | ﹤0.01% |
90,984
+89,804
| +7,611% | +$997K |
|
2600
Colony Bankcorp
CBAN
$465M
| $800K | ﹤0.01% |
84,878
+4,700
| +6% | +$44.6K |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.